文献速递心力衰竭与心肌病心律失常

尸检未明确死因的心脏性猝死中隐匿性心肌病及其对家族的意义

Concealed Cardiomyopathy in Autopsy-Inconclusive Cases of Sudden Cardiac Death and Implications for Families.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

本研究在91例尸检未明确死因的心脏性猝死病例中,依据美国医学遗传学与基因组学学会指南进行基因变异致病性分类,发现20例携带致病性变异,其中70%位于心肌病相关基因。基因阳性亲属中近三分之二在初评或随访中表现出可观察表型,27名基因阴性一级亲属解除持续筛查。结论提示应超越尸检表型导向,纳入心肌病相关基因评估以识别隐匿性心肌病并优化家族管理。

要点

  • 尸检未明确死因的猝死病例中,隐匿性心肌病相关基因变异占可干预变异的70%。
  • 基因阳性亲属近三分之二在初评或随访中呈现可观察表型。
  • 综合评估应纳入心肌病相关基因,而不仅限于原发性心律失常基因。

核心结论

  • 尸检后仅按表型导向进行基因检测会低估隐匿性心肌病的检出。
  • 对猝死者进行全面评估应同时纳入心肌病相关基因与原发性心律失常基因,以优化家族管理。

研究设计与样本

  • 研究纳入91例尸检未明确死因的心脏性猝死病例,平均年龄25.4±10.7岁,采用标准化裁定框架识别。
  • 基因变异按美国医学遗传学与基因组学学会指南进行致病性分类,并在可能情况下进行家族随访。

主要发现

  • 91例中检出20个致病性变异,无论尸检有无亚诊断性发现,检出率相似(25.5% vs 18.2%;P=0.398)。
  • 心肌病相关基因携带70%的临床可干预变异,且在尸检有亚诊断性结构改变的病例中占比更高(79% vs 21%;P=0.038)。
  • 20个致病性变异中6个位于致心律失常性心肌病相关基因。
  • 基因阳性亲属中近三分之二在初评或后续随访中具有可观察表型,27名基因阴性一级亲属解除持续筛查。

临床怎么用

  • 对尸检未明确死因的心脏性猝死病例,基因检测应涵盖心肌病相关基因,而不仅限于原发性心律失常基因。
  • 基因阳性亲属需进行表型评估与随访,基因阴性一级亲属可考虑解除持续筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic testing following sudden cardiac death (SCD) is currently guided by autopsy findings, despite the inherent challenges of autopsy examination and mounting evidence that malignant arrhythmia may occur before structural changes in inherited cardiomyopathy, so-called "concealed cardiomyopathy" (CCM). OBJECTIVES: The authors sought to identify the spectrum of genes implicated in autopsy-inconclusive SCD and describe the impact of identifying CCM on the ongoing care of SCD families. METHODS: Using a standardized framework for adjudication, autopsy-inconclusive SCD cases were identified as having a structurally normal heart or subdiagnostic findings of uncertain significance on autopsy. Genetic variants were classified for pathogenicity using the American College of Medical Genetics and Genomics guidelines. Family follow-up was performed where possible. RESULTS: Twenty disease-causing variants were identified among 91 autopsy-inconclusive SCD cases (mean age 25.4 ± 10.7 years) with a similar rate regardless of the presence or absence of subdiagnostic findings (25.5% vs 18.2%; P = 0.398). Cardiomyopathy-associated genes harbored 70% of clinically actionable variants and were overrepresented in cases with subdiagnostic structural changes at autopsy (79% vs 21%; P = 0.038). Six of the 20 disease-causing variants identified were in genes implicated in arrhythmogenic cardiomyopathy. Nearly two-thirds of genotype-positive relatives had an observable phenotype either at initial assessment or subsequent follow-up, and 27 genotype-negative first-degree relatives were released from ongoing screening. CONCLUSIONS: Phenotype-directed genetic testing following SCD risks under recognition of CCM. Comprehensive evaluation of the decedent should include assessment of genes implicated in cardiomyopathy in addition to primary arrhythmias to improve diagnosis of CCM and optimize care for families.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Isbister JC, Nowak N, Yeates L, et al. Concealed Cardiomyopathy in Autopsy-Inconclusive Cases of Sudden Cardiac Death and Implications for Families. J Am Coll Cardiol. 2022. PMID: 36423990. doi:10.1016/j.jacc.2022.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。